These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3773645)

  • 21. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.
    Bonnet J; Loiseau AM; Orvoen M; Bessin P
    Agents Actions; 1981 Dec; 11(6-7):559-62. PubMed ID: 7340441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw.
    Fernandes ES; Passos GF; Campos MM; Araújo JG; Pesquero JL; Avelllar MC; Teixeira MM; Calixto JB
    Br J Pharmacol; 2003 Jul; 139(5):973-81. PubMed ID: 12839871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.
    Henriques MG; Rae GA; Cordeiro RS; Williams TJ
    Br J Pharmacol; 1992 Jul; 106(3):579-82. PubMed ID: 1504742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleural eosinophil infiltration induced by PAF-acether is not a desensitizable phenomenon.
    Silva PM; Martins MA; Castro-Faria-Neto HC; Bozza PT; Cruz HN; Dias MT; Cordeiro RS; Vargaftig BB
    Braz J Med Biol Res; 1990; 23(10):1009-13. PubMed ID: 2101050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina.
    Henriques MG; Fernandes PD; Weg VB; Yunes RA; Cordeiro RS; Calixto JB
    Agents Actions; 1991 Jul; 33(3-4):272-8. PubMed ID: 1719783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
    Sato A; Oe K; Yamanaka H; Yokoyama I; Ebina K
    Eur J Pharmacol; 2014 Dec; 745():46-51. PubMed ID: 25455842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of inflammatory paw oedema by cysteamine in the rat.
    Salam OM
    Pharmacol Res; 2002 Apr; 45(4):275-84. PubMed ID: 12030790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice.
    Amorim CZ; Martins MA; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1992 Jan; 211(1):29-33. PubMed ID: 1618265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists.
    Hellewell PG; Williams TJ
    Br J Pharmacol; 1989 May; 97(1):171-80. PubMed ID: 2720306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A; Cutuli VM; De Bernardis E; Leonardi G; Amico-Roxas M
    Pharmacol Res; 1995 Jan; 31(1):67-72. PubMed ID: 7784308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice.
    Amorim CZ; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1993 May; 236(2):301-4. PubMed ID: 8319756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
    Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
    Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet involvement in rat paw edema induced by 2-methoxy-PAF.
    Silva PM; Cordeiro RS; Martins MA; Henriques MG; Vargaftig BB
    Inflammation; 1986 Dec; 10(4):393-401. PubMed ID: 3793206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.
    da Motta JI; Cunha FQ; Vargaftig BB; Ferreira SH
    Br J Pharmacol; 1994 May; 112(1):111-6. PubMed ID: 8032630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.